Home
Padagis

Padagis Market Share Analysis for May 2026

ALLEGAN, Mich., Oct. 28, 2025 /PRNewswire/ — Padagis®, a leading generic pharmaceuticals company, has announced an investment of over $36 million to expand its manufacturing operations in Minneapolis, Minnesota, which includes the expansion...

Health > Biotechnology and Pharmaceuticals

Domainpadagis.com

Year Founded2004

Employees201 - 500

Annual Revenue--

Padagis

Padagis (including company regionals)

padagis.com

See more website traffic and engagement information

Total visits to Padagis's top domains

Understand Padagis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

padagis.com26.3K

See more with Sales Intelligence

Avg. visit duration in Padagis's top domains

Analyze Padagis engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

padagis.com00:00:12

See more with Sales Intelligence

Avg. pageviews on Padagis's top domains

See how Padagis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

padagis.com1.33

See more with Sales Intelligence

Padagis top competitors by domain

Top similar sites in May 2026, ranked by their affinity

perrigo.comCompany NamePerrigo CompanyEmployees5001 - 10000HQIreland, DublinAnnual revenue> $1BTotal visits129.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Padagis

These are the website technologies, by industry, used by Padagis top domains

Widget (4)

Twemoji

Advertising (2)

DoubleClick

Mobile (2)

Meta Viewport

Recruitment (2)

Jobvite

More Technologies

7

See all

News & Signals from Padagis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPadagis LLC launches Brinzolamide Ophthalmic Suspension.Padagis announces the launch of Brinzolamide Ophthalmic Suspension with CGT exclusivity.

NewsPadagis LLC sold assets to Emilia Cosmetics Group on Jul 13th '09.The deal has a symbolic dimension, because Padagis, when it was owned by Perrigo, sold the factory to Emilia 14 years ago.

NewsPadagis LLC launched Tazarotene Gel and Methylphenidate Transdermal System on Jun 9th '23.Padagis today announced the launch of Tazarotene Gel (generic to Tazorac® Gel) and Methylphenidate Transdermal System (authorized generic to Daytrana®).